BENLYSTA belimumab 120 mg powder for injection vial

GlaxoSmithKline Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 939d5106c8975918
Product Name: BENLYSTA belimumab 120 mg powder for injection vial
Artg Id: 173077
Artg Name: BENLYSTA belimumab 120 mg powder for injection vial
Sponsor: GlaxoSmithKline Australia Pty Ltd
Company Detail Path: /organization/glaxosmithkline-australia-pty-ltd
Artg Date: 2012-10-18
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/9cc2c577e04fda0e53eeae12e240e0b6.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/677c40a736a604c7072e0284c10fac69.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

939d5106c8975918

Type

Standard